PHREESIA INC (PHR) Stock Fundamental Analysis
USA - NYSE:PHR - US71944F1066 - Common Stock
23.28 USD
-0.22 (-0.94%)
23.01 USD
-0.27 (-1.16%)
Taking everything into account, PHR scores 4 out of 10 in our fundamental rating. PHR was compared to 35 industry peers in the Health Care Technology industry. PHR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PHR had negative earnings in the past year.
PHR had a positive operating cash flow in the past year.
PHR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PHR reported negative operating cash flow in multiple years.
1.2 Ratios
PHR has a better Return On Assets (-5.89%) than 71.43% of its industry peers.
Looking at the Return On Equity, with a value of -8.07%, PHR is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.89% | ||
| ROE | -8.07% | ||
| ROIC | N/A |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHR's Gross Margin of 68.02% is fine compared to the rest of the industry. PHR outperforms 71.43% of its industry peers.
PHR's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PHR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.02% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
2. Health
2.1 Basic Checks
PHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
PHR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, PHR has more shares outstanding
The debt/assets ratio for PHR is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 6.04 indicates that PHR is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.04, PHR belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
The Debt to FCF ratio of PHR is 0.42, which is an excellent value as it means it would take PHR, only 0.42 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of PHR (0.42) is better than 80.00% of its industry peers.
PHR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PHR has a Debt to Equity ratio of 0.02. This is in the better half of the industry: PHR outperforms 62.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 6.04 |
ROIC/WACCN/A
WACC9.51%
2.3 Liquidity
PHR has a Current Ratio of 2.12. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
PHR has a Current ratio (2.12) which is in line with its industry peers.
A Quick Ratio of 2.12 indicates that PHR has no problem at all paying its short term obligations.
PHR has a Quick ratio of 2.12. This is comparable to the rest of the industry: PHR outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 |
3. Growth
3.1 Past
PHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.50%, which is quite impressive.
The Revenue has grown by 15.31% in the past year. This is quite good.
Measured over the past years, PHR shows a very strong growth in Revenue. The Revenue has been growing by 27.46% on average per year.
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.23%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%14.83%
3.2 Future
The Earnings Per Share is expected to grow by 55.33% on average over the next years. This is a very strong growth
Based on estimates for the next years, PHR will show a quite strong growth in Revenue. The Revenue will grow by 12.19% on average per year.
EPS Next Y85.52%
EPS Next 2Y49.7%
EPS Next 3Y55.33%
EPS Next 5YN/A
Revenue Next Year14.04%
Revenue Next 2Y13.08%
Revenue Next 3Y12.84%
Revenue Next 5Y12.19%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
PHR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 94.66, PHR can be considered very expensive at the moment.
PHR's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. PHR is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.66 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHR is on the same level as its industry peers.
PHR's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50 | ||
| EV/EBITDA | 671.51 |
4.3 Compensation for Growth
PHR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHR's earnings are expected to grow with 55.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.7%
EPS Next 3Y55.33%
5. Dividend
5.1 Amount
No dividends for PHR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.28
-0.22 (-0.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners96.06%
Inst Owner Change4.35%
Ins Owners4.73%
Ins Owner Change-1.29%
Market Cap1.39B
Analysts85
Price Target34.83 (49.61%)
Short Float %5.15%
Short Ratio3.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)78.63%
Min EPS beat(2)41.66%
Max EPS beat(2)115.6%
EPS beat(4)4
Avg EPS beat(4)51.25%
Min EPS beat(4)8.94%
Max EPS beat(4)115.6%
EPS beat(8)8
Avg EPS beat(8)37.38%
EPS beat(12)12
Avg EPS beat(12)31.19%
EPS beat(16)15
Avg EPS beat(16)26.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.27%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)-0.18%
Revenue beat(4)0
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)-0.18%
Revenue beat(8)2
Avg Revenue beat(8)-0.13%
Revenue beat(12)5
Avg Revenue beat(12)0.4%
Revenue beat(16)9
Avg Revenue beat(16)1.43%
PT rev (1m)5.93%
PT rev (3m)8.64%
EPS NQ rev (1m)80.51%
EPS NQ rev (3m)79.49%
EPS NY rev (1m)0%
EPS NY rev (3m)34.76%
Revenue NQ rev (1m)-0.49%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.66 | ||
| P/S | 3.1 | ||
| P/FCF | 50 | ||
| P/OCF | 26.96 | ||
| P/B | 4.68 | ||
| P/tB | 9.83 | ||
| EV/EBITDA | 671.51 |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.25
Fwd EY1.06%
FCF(TTM)0.47
FCFY2%
OCF(TTM)0.86
OCFY3.71%
SpS7.51
BVpS4.97
TBVpS2.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.89% | ||
| ROE | -8.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.02% | ||
| FCFM | 6.2% |
ROA(3y)-33.2%
ROA(5y)-26.37%
ROE(3y)-45.91%
ROE(5y)-35.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.16%
GM growth 5Y1.12%
F-Score7
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 2.35 | ||
| Cap/Depr | 84.53% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 2655.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 2.12 | ||
| Altman-Z | 6.04 |
F-Score7
WACC9.51%
ROIC/WACCN/A
Cap/Depr(3y)91.68%
Cap/Depr(5y)107.3%
Cap/Sales(3y)7.37%
Cap/Sales(5y)9.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.23%
EPS Next Y85.52%
EPS Next 2Y49.7%
EPS Next 3Y55.33%
EPS Next 5YN/A
Revenue 1Y (TTM)15.31%
Revenue growth 3Y25.34%
Revenue growth 5Y27.46%
Sales Q2Q%14.83%
Revenue Next Year14.04%
Revenue Next 2Y13.08%
Revenue Next 3Y12.84%
Revenue Next 5Y12.19%
EBIT growth 1Y73.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year245.92%
EBIT Next 3Y64.05%
EBIT Next 5Y36.17%
FCF growth 1Y132.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y186.75%
OCF growth 3YN/A
OCF growth 5Y108.09%